Table 4.
Correlation Between DTYMK Expression and Clinicopathological Features of HCC in Our Validation Cohort
| Clinicopathological Variables | n | DTYMK Expression | P-value | |
|---|---|---|---|---|
| High (63) | Low (23) | |||
| Age | 50 | 47 | 0.369 | |
| Sex | 1 | |||
| Male | 73 | 53 | 20 | |
| Female | 13 | 10 | 3 | |
| AFP, ng/L | 0.226 | |||
| <200 | 42 | 28 | 14 | |
| ≥200 | 44 | 35 | 9 | |
| Tumor size, cm | 0.468 | |||
| ≤5 | 50 | 35 | 15 | |
| >5 | 36 | 28 | 8 | |
| Tumor number | 0.622 | |||
| Solitary | 51 | 36 | 15 | |
| Multiple (≥2) | 35 | 27 | 8 | |
| PVTT | 0.427 | |||
| Absence | 60 | 42 | 18 | |
| Presence | 26 | 21 | 5 | |
| TNM stage | 0.808 | |||
| Early (I & II) | 45 | 32 | 13 | |
| Advance (III & IV) | 41 | 31 | 10 | |
| Differentiation grade | 0.035 | |||
| Well | 59 | 39 | 20 | |
| Poor | 27 | 24 | 3 | |
Notes: Bold text indicates a significant difference.
Abbreviations: AFP, alpha fetus protein; PVTT, portal vein tumor thrombosis.